Topic summary
Case-fatality rate
Extracted from the Wikipedia article Case fatality rate.
References
- ^
- ^
- ^ . Elsevier. 2020-03-25. Archived from the original(PDF) on 2020-03-27.
- ^
- ^
- ^.
- ^
- ^ .
- ^ 2020.
- ^ 2020.
- ^ . 2011-05-05. p. 37. Archived(PDF) from the original on 14 May 2015 2015.
- ^ 22. doi:10.3201/eid1201.050979. PMC 3291398. PMID 16494711. Archived from the original on 2009-10-06.
- ^ . Journal of Epidemiology and Community Health. 62 (6): 555–559. doi:10.1136/jech.2007.064030. ISSN 0143-005X. PMID 18477756. S2CID 34200426.
- ^.
- ^ S14. doi:10.1046/j.1440-1843.2003.00518.x. ISSN 1323-7799. PMC 7169193. PMID 15018127.
- ^
- ^
- ^ 487. doi:10.1093/trstmh/tru092. PMC 4632853. PMID 24980556 – via Oxford University Press.
- ^ . PMC 8365934. PMID 34399718. S2CID 237056056.
- ^
- ^ (7th ed.). U.S. Government Printing Office. ISBN . Archived from the original(PDF) on 2015-02-09.
- ^
- ^ 1207. doi:10.1016/S0140-6736(07)60566-2. PMID 17416264. S2CID 208790222.
- ^ 2128. doi:10.1016/s0140-6736(12)61728-0. hdl:10292/13775. ISSN 0140-6736. PMC 10790329. PMID 23245604. S2CID 1541253.
- ^ . ISSN 1932-6203. PMC 3070694. PMID 21483732.
- ^.
- ^ e27. doi:10.1093/cid/ciaa520. ISSN 1058-4838. PMC 8739754. PMID 32369575.
Among the 7 PAM survivors with a confirmed diagnosis [19–24], the following medications were used for treatment: intravenous amphotericin B (7/7), intrathecal amphotericin B (5/7), azoles (6/7), rifampin (6/7), azithromycin (4/7), miltefosine (4/7), and dexamethasone (5/7). The median time from symptom onset to treatment was 2.5 days (range, 0–5; Table 5). The 4 US survivors received deoxycholate (conventional, nonliposomal) formulations of amphotericin B; formulations for the 3 international survivors were unknown.
- ^ 2014.